Noradrenaline (base) 4mg/4ml concentrate for solution for infusion ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

noradrenaline (base) 4mg/4ml concentrate for solution for infusion ampoules

base) 4mg/4ml concentrate for solution for infusion ampoules (pfizer ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

Noradrenaline (base) 4mg/4ml concentrate for solution for infusion ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

noradrenaline (base) 4mg/4ml concentrate for solution for infusion ampoules

base) 4mg/4ml concentrate for solution for infusion ampoules (aguettant ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules

base) 8mg/8ml concentrate for solution for infusion ampoules (aguettant ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

qarziba dinutuximab beta 4.5 mg/ml concentrate for solution for infusion, 20 mg/4.5 ml vial

recordati rare diseases australia pty ltd - dinutuximab beta, quantity: 4.5 mg/ml - solution - excipient ingredients: polysorbate 20; hydrochloric acid; sucrose; water for injections; histidine - qarziba is indicated for the treatment of high-risk neuroblastoma in patients who have previously received induction chemotherapy and achieved at least a partial response.

Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flolan 1.5mg powder and solvent (ph12) for solution for infusion vials

ph12) for solution for infusion vials (glaxosmithkline uk ltd - epoprostenol sodium - powder and solvent for solution for infusion - 1.5mg

Flolan 500microgram powder and solvent (pH12) for solution for infusion vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flolan 500microgram powder and solvent (ph12) for solution for infusion vials

ph12) for solution for infusion vials (glaxosmithkline uk ltd - epoprostenol sodium - powder and solvent for solution for infusion - 500microgram

FEIBA 50units/ml (1,000unit) powder and 20ml solvent for solution for infusion vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

feiba 50units/ml (1,000unit) powder and 20ml solvent for solution for infusion vials

1,000unit) powder and 20ml solvent for solution for infusion vials (takeda uk ltd - factor viii inhibitor bypassing fraction - powder and solvent for solution for infusion - 1000unit

Zenalb 4.5% solution for infusion 250ml bottles United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zenalb 4.5% solution for infusion 250ml bottles

bio products laboratory ltd - albumin solution human - solution for infusion - 45mg/1ml

Zenalb 4.5% solution for infusion 500ml bottles United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zenalb 4.5% solution for infusion 500ml bottles

bio products laboratory ltd - albumin solution human - solution for infusion - 45mg/1ml

Zenalb 20% solution for infusion 100ml bottles United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zenalb 20% solution for infusion 100ml bottles

bio products laboratory ltd - albumin solution human - solution for infusion - 200mg/1ml